ABSTRACT

Green synthesis is an emerging method for deriving nanoparticles present in natural plants for use in nanomedicine. Written by experts in the field, Green Synthesis in Nanomedicine and Human Health showcases the exciting developments of this specialty and its potential for promoting human health and well-being.

This book gives practical information on novel preparation methods for identifying nanoparticles present in natural plants. It discusses applications of nanoparticles in combating communicable, non-communicable and vector-borne diseases. It also explores the potential for nanoparticles to combat antimicrobial resistance through improvements in treatment methods, diagnostics and drug delivery systems.

  • Features scientific evidence of opportunities for integrating indigenous flora into nanomedicine to develop cost-effective therapeutic and diagnostic solutions for diseases, including cancer, tuberculosis, malaria and diabetes.
  • Places green synthesis and nanomedicine in the African orthodox and traditional healthcare context.
  • Provides policymakers with scientific evidence to inform policies for controlling or mitigating dangerous diseases.

This book is essential reading for students, scientists, policymakers and practitioners of nanotechnology, and will appeal to anyone with an interest in integrating traditional African healthcare and Western medicine.

section Section I|14 pages

Green Synthesis of Nanoparticles from Natural Plant Parts

section Section II|48 pages

Nanotechnology for Treatment of Non-Communicable Diseases

chapter 1|14 pages

Cancer Nanotheranostics

Next-Generation Early Detection and Treatment Prioritization for Cancers Using Phytonanotechnology

chapter 3|18 pages

Green Nanoparticles

An Alternative Therapy for Oral Candidiasis

section Section IV|22 pages

Nanotechnology for Treatment of Vector-Borne Diseases

section Section V|124 pages

Nanotechnology in Combating Antimicrobial Resistance

section Section VI|68 pages

Cross-Cutting Issues

chapter 12|20 pages

Nanomedicines for the Treatment of Infectious Diseases

Formulation, Delivery and Commercialization Aspects